Eline Abma
Show
Sort by
-
- Journal Article
- A1
- open access
Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumors
-
Fluorescence-guided surgery using indocyanine green in dogs with superficial solid tumours
-
OncoCiDia : an innovative cancer treatment combining a vascular disrupting agent with targeted radiotherapy : preliminary results in dogs
(2019) -
- Journal Article
- A1
- open access
Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients
-
- Journal Article
- A1
- open access
Treatment of a malignant peripheral nerve sheath tumor by intravenous administration of combretastatin A4-phosphate in a dog
-
Biosecurity measures for dog merchants and canine breeding kennels
-
A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers
-
Clinical use of organic near-infrared fluorescent contrast agents in image-guided oncologic procedures and its potential in veterinary oncology
-
Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs
-
A dose-escalation study of combretastatin A4-phosphate in healthy dogs